Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
As the study authors note, GLP-1 receptor agonists are widely used in metabolic and weight-management medicine, but their potential influence on botulinum toxin type A (BoNT-A) pharmacodynamics has not previously been examined. Study design Rahman and colleagues used a computer-based microsimulation platform, AesthetiSIM, to examine potential interactions between GLP-1 RAs and BoNT-A
Published March 26, 2024
Semaglutide is approved for adults with obesity or those overweight with certain weight-related health conditions
What is the best form of NAD to take
A new study from Case Western Reserve University School of Medicine reveals that popular GLP-1 drugs for treating diabetes or prescribed for weight loss purposes, such as Wegovy and Ozempic, may significantly reduce alcohol misuse and alcohol use disorder
What Patients Should Ask Before Considering Peptide Therapy What is the exact clinical goal, and what evidence supports this peptide for that goal
